Purple Biotech (PPBT) Non Operating Income (2014 - 2026)

Purple Biotech (PPBT) has 12 years of Non Operating Income data on file, last reported at -$2.2 million in Q1 2026.

• On a quarterly basis, Non Operating Income fell 127.58% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$2.2 million, a 46.44% increase from a year earlier, with the FY2025 full-year figure at $966000.0, down 74.07% from the prior year.
• Non Operating Income for Q1 2026 stood at -$2.2 million, down from $197000.0 in the prior quarter.
• Over the last five years, Non Operating Income for PPBT reached as high as $197000.0 in Q4 2025 and fell as low as -$2.2 million in Q1 2026.
• Historically, Non Operating Income has averaged -$591470.6 across 5 years, with a median of -$558000.0 in 2022.
• Across the five-year window, Non Operating Income soared 165.79% in 2023 and plunged 4272.0% in 2024, its largest moves.
• Year by year, Non Operating Income stood at -$558000.0 in 2022, then plunged by 152.33% to -$1.4 million in 2023, then surged by 57.32% to -$601000.0 in 2024, then jumped by 132.78% to $197000.0 in 2025, then plunged by 1197.46% to -$2.2 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$2.2 million in Q1 2026, $197000.0 in Q4 2025, and -$62000.0 in Q3 2025.